H. P. Palmer
YOU?
Author Swipe
View article: M24 3-year real world outcomes with benralizumab for severe eosinophilic asthma
M24 3-year real world outcomes with benralizumab for severe eosinophilic asthma Open
The monoclonal antibody, benralizumab targets the IL-5R α subunit on eosinophils, inhibiting their maturation and activation, thus disrupting the eosinophilic pathway of inflammation. Real-life data has shown the short-term efficacy of be…
View article: Submission to Climate Change Commission 2021 Draft Advice Document
Submission to Climate Change Commission 2021 Draft Advice Document Open
Our submission to the Climate Change Commission is for its recommendations to
\nGovernment to incorporate the NZ Dryland Forests Initiative’s vision of durable hardwood
\nindustries based on 60,000 hectares of eucalypt forests being establ…